These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 2074163
1. A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis. Bellavance AJ, Meloche JP. Headache; 1990 Nov; 30(11):710-5. PubMed ID: 2074163 [Abstract] [Full Text] [Related]
2. Prophylaxis of migraine: a comparison between naproxen sodium and pizotifen. Behan PO, Connelly K. Headache; 1986 May; 26(5):237-9. PubMed ID: 3522482 [No Abstract] [Full Text] [Related]
3. Naproxen sodium in the treatment of migraine. Johnson ES, Ratcliffe DM, Wilkinson M. Cephalalgia; 1985 Mar; 5(1):5-10. PubMed ID: 3886154 [Abstract] [Full Text] [Related]
4. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. Cleland PG, Barnes D, Elrington GM, Loizou LA, Rawes GD. Eur Neurol; 1997 Mar; 38(1):31-8. PubMed ID: 9252796 [Abstract] [Full Text] [Related]
6. Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine. Havanka-Kanniainen H, Hokkanen E, Myllylä VV. Cephalalgia; 1987 Mar; 7(1):7-13. PubMed ID: 3555838 [Abstract] [Full Text] [Related]
7. Pizotifen once daily in the prophylaxis of migraine: results of a multi-centre general practice study. Crowder D, Maclay WP. Curr Med Res Opin; 1984 Mar; 9(4):280-5. PubMed ID: 6391831 [Abstract] [Full Text] [Related]
8. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine. Mastrosimone F, Iaccarino C, de Caterina G. J Med; 1992 Mar; 23(1):1-16. PubMed ID: 1573338 [Abstract] [Full Text] [Related]
9. [Effectiveness of tolfenamic acid in the prevention of migraine]. Vaitkus A, Pauza V. Medicina (Kaunas); 2002 Mar; 38(3):296-303. PubMed ID: 12474702 [Abstract] [Full Text] [Related]
10. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [Abstract] [Full Text] [Related]
11. Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine. Rascol A, Montastruc JL, Rascol O. Headache; 1986 Feb; 26(2):83-5. PubMed ID: 3514549 [No Abstract] [Full Text] [Related]
12. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Headache; 1990 Nov; 30(11):705-9. PubMed ID: 2074162 [Abstract] [Full Text] [Related]
13. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Andersson PG, Hinge HH, Johansen O, Andersen CU, Lademann A, Gøtzsche PC. Cephalalgia; 1989 Mar; 9(1):29-32. PubMed ID: 2650879 [Abstract] [Full Text] [Related]
14. Placebo, 1-isopropylnoradrenochrome-5-monosemicarbazono and pizotifen in migraine prophylaxis. Kangasniemi P. Headache; 1979 May; 19(4):219-22. PubMed ID: 156165 [No Abstract] [Full Text] [Related]
15. Treatment of acute migraine attack: naproxen and placebo compared. Nestvold K, Kloster R, Partinen M, Sulkava R. Cephalalgia; 1985 Jun; 5(2):115-9. PubMed ID: 3893730 [Abstract] [Full Text] [Related]
16. Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation. Vilming S, Standnes B, Hedman C. Cephalalgia; 1985 Mar; 5(1):17-23. PubMed ID: 3986895 [Abstract] [Full Text] [Related]
18. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis. Osterman PO. Acta Neurol Scand; 1977 Jul; 56(1):17-28. PubMed ID: 327746 [Abstract] [Full Text] [Related]
19. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Sargent J, Solbach P, Damasio H, Baumel B, Corbett J, Eisner L, Jessen B, Kudrow L, Mathew N, Medina J. Headache; 1985 Sep; 25(6):320-4. PubMed ID: 3902723 [No Abstract] [Full Text] [Related]
20. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D. Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]